Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare Conference
Rhea-AI Summary
Aadi Bioscience (NASDAQ: AADI) has announced its upcoming participation in the TD Cowen 45th Annual Healthcare Conference in Boston, MA. The conference is scheduled for March 3-5, 2025, where CEO Dave Lennon, PhD, will deliver a company overview presentation on Monday, March 3, 2025, from 9:50 – 10:20 AM ET.
The presentation will be accessible through a live webcast on the company's IR website pages, with replay availability for approximately 30 days after the event.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, AADI declined 2.51%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
The presentation will be webcast live on the IR pages of the Aadi Bioscience website and will be available for replay for approximately 30 days following the investor event.
About Aadi Bioscience
Aadi is a precision oncology company with a vision to make bold choices in applying technology to efficiently deliver improved precision oncology therapies for people living with difficult-to-treat cancers. More information on the Company is available on the Aadi website at www.aadibio.com and connect with us on LinkedIn.
Contact:
IR@aadibio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/aadi-bioscience-to-present-at-the-td-cowen-45th-annual-healthcare-conference-302383012.html
SOURCE Aadi Bioscience
